Sophia Genetics, ArcherDx Ink Deal to Combine Technologies | GenomeWeb

NEW YORK (GenomeWeb) — Sophia Genetics and ArcherDx today announced that they have formed a partnership to combine their respective technologies to provide an integrated analytical and next-generation sequencing sample preparation offering for cancer research.

Under the terms of the deal, Sophia will incorporate ArcherDx's FusionPlex, VariantPlex, and Reveal ctDNA kits into its Data-Driven Medicine analytical platform, and offer the combined solutions to its network of more than 215 hospital and laboratory customers globally. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Feb
23
Sponsored by
NuGEN

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.